Tumor Mutation Burden, Expressed Neoantigens and the Immune Microenvironment in Diffuse Gliomas.
Guangyang YuYing PangMythili MerchantChimene A KesserwanVineela GangalapudiAbdalla AbdelmaksoudAlice RanjanOlga KimJun S WeiHsien-Chao ChouXinyu WenSivasish SindiriYoung K SongLiqiang XiRosandra N KaplanTerri S ArmstrongMark R GilbertKenneth D AldapeJaved KhanJing WuPublished in: Cancers (2021)
TMB was inversely correlated with immune score in IDH-wildtype gliomas and showed no correlation in IDH-mutant tumors. APP was correlated with immune score and may be further investigated as a biomarker for response to immunotherapy in gliomas. Studies of germline variants in a larger glioma cohort are warranted.